Maternal And Fetal Outcomes In Patients With Hypertrophic Cardiomyopathy

Cassandra Garraud,Parvathy Sankar,Ijeoma Nduka,Karlee Hoffman,Bala Pushparaji

DOI: https://doi.org/10.1016/j.cardfail.2023.10.176

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction Hypertrophic cardiomyopathy (HCM) is increased ventricular mass which can be septal or apical in the absence of hypertension or aortic stenosis. More than 15 mm is classified as moderate and more than 20 mm is severe. HCM is an autosomal dominant disease that affects sarcomere proteins which leads to myocardial disarray and fibrosis. Symptoms include syncope, arrhythmia, sudden cardiac death, and heart failure. Pregnant HCM patients pose greater risk if they have preexisting LV outflow obstruction. Our hypothesis is that a multidisciplinary team involving maternal-fetal medicine and cardiology is needed to care for these patients. Method The maternal-fetal medicine database at our institution was reviewed to identify HCM patients who receive obstetric care via our multidisciplinary clinic. A retrospective chart review was performed to identify maternal characteristics and outcome of pregnancies. Results Four patients with HCM were identified. All were planned pregnancies and received preconception counseling. All pregnancies were singleton and carried to term. Genetic testing was noted in three patients, one patient had a positive family history of HCM in her mother and sister. One of the patients had systolic anterior motion of the mitral valve (SAM) and mitral regurgitation. Three pre-pregnancy gradients were below 10 mmHg, 0 mmHg for most intra-pregnancy gradients. Three of the patients had history of arrhythmia, none had ICD use, and two patients had adverse fetal outcomes. For patient #3 and patient #4, it is still unclear regarding adverse circumstances. Conclusion Data is limited in regards to pregnancy outcomes in patients with HCM. Increased cardiac output and heart rate during pregnancy and delivery pose risks to HCM patients by increasing the LVOT gradient and increasing the risk of pulmonary edema. Pregnancy is not recommended in women with symptomatic LVOT gradient or LV systolic function <40%. Prior studies have proposed that baseline NYHA and pre-pregnancy arrhythmias are predictors of cardiac complications which is similar to the results found here. Conflicting data is present when it comes to LVOT gradient and its association to poor cardiac outcome. From our analysis <10 mmHg pressure gradients and lower NYHA class were a reasonable baseline in terms of preconception counseling although more data is ultimately needed to further risk stratify and delineate patients with adverse fetal outcomes.

cardiac & cardiovascular systems